در این بخش مطالب مرتبط با بیماری آرپی- آخرین مقالات و روند درمانهای نوین قرار میگیرد
Blue light from smart phones and digital devices could raise risk of blindness
Scientists reverse congenital blindness in mouse model
Scientists report novel gene therapy that halts vision loss in canine model of blinding disease
ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals
Understanding Retinitis Pigmentosa
Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa
Open PDF
Visual Acuity Change Over 24 Months and its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease
Gene Therapy for Blindness
Companion animals: Translational scientist’s new best friends
X linked retinoschisis
Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview
PROGRESS IN RETINAL AND EYE RESEARCH 2003
Ophthalmic features of Friedreich ataxia
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial
The retina translates light into a language the brain understands
Bilateral Symmetry of Visual Function Loss in Cone–Rod Dystrophies
Characterization of Visual Function, Interocular Variability and Progression Using Static Perimetry–Derived Metrics in RPGR-Associated Retinopathy
The Key to Commercializing Revolutionary Gene Therapies and Other Orphan Drugs: High-Touch Services that Enhance Patient Outcomes
Development of a Chromatic Pupillography Protocol for the First Gene Therapy Trial in Patients With CNGA3- Linked Achromatopsia
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial
How to use the ICF
Eye movement training is most effective when it involves a task-relevant sensorimotor decision
Inherited Retinal Degenerations: Current Landscape and Knowledge Gaps
G-substrate and Phosphatase Activation in Retinitis Pigmentosa
Methodological Insights for Randomized Clinical Trials of Retinitis Pigmentosa Lessons Learned From a Trial of Valproic Acid
Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of Blindness
Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa
UPDATE ON RESEARCH FOR RP TREATMENT: VITAMIN A PALMITATE, OMEGA-3-RICH FISH AND LUTEIN
Visual Search Behavior in Individuals With Retinitis Pigmentosa During Level Walking and Obstacle Crossing
http://iran-rp.ir/wp-content/uploads/2018/09/uk-XLRS.pdf
Tunnel Vision Prismatic Field Expansion: Challenges and Requirements
Treating the Eyes to Help the Brain
Toward the Mutational Landscape of Autosomal Dominant Retinitis Pigmentosa: A Comprehensive Analysis of 258 Spanish Families
The Spectrumof Structural and Functional Abnormalities in Female Carriers of Pathogenic Variants in the RPGR Gene
The Economic Impact of Blindness in Europe
Significant Relationship of Visual Field Sensitivity in Central 108 to Thickness of Retinal Layers in Retinitis Pigmentosa
Risk Factors for Posterior Subcapsular Cataract in Retinitis Pigmentosa
HORAMA announces initiation of a Phase I/II Clinical Study for HORA-PDE6B, in Retinitis Pigmentosa (RP)